|
Selinexor 40 mg Clinical Trials
1 actively recruiting trial across 1 location
Durham, North Carolina1 trial
HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM
Duke University Health System
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.